A Phase I clinical trial in healthy volunteers to evaluate a TRPC4/5 inhibitor.
Phase of Trial: Phase I
Latest Information Update: 07 Nov 2017
At a glance
- Drugs Transient receptor potential channel inhibitors (Primary)
- Indications Anxiety disorders; CNS disorders; Depression
- Focus Adverse reactions
- 07 Nov 2017 New trial record